We are at an early but critical stage. Your donations directly fund the scientific milestones that will one day lead to treatments for children with SLC1A4 Deficiency.
Research into SLC1A4 Deficiency follows a defined pathway. We have completed the first two milestones and are actively fundraising for Step 3.
The natural history study currently underway is a critical early step in the research pipeline. Without systematic data, researchers cannot:
Building the cellular and animal models needed to study disease mechanisms and test potential therapies before human trials.
Identifying and evaluating potential treatments — including gene therapy and small molecule approaches — in preclinical models.
Moving the most promising therapeutic candidates into human trials, giving affected children access to potential treatments.